Glucagon-like peptide-1/ja: Difference between revisions
Glucagon-like peptide-1/ja
Created page with " " |
Created page with "== こちらも参照== * Glucagon-like peptide 1 receptor/ja * Glucagon-like peptide-2/ja * 2型糖尿病 * GLP-1受容体作動薬 : albiglutide/ja, dulaglutide/ja, exenatide/ja, liraglutide/ja, lixisenatide/ja, semaglutide/ja, tirzepatide/ja * ジペプチジルペプチダーゼ4 * Glucose-dependent insulinotropic peptide/ja" Tags: Mobile edit Mobile web edit |
||
| Line 84: | Line 84: | ||
</div> | </div> | ||
== こちらも参照== | |||
* [[Glucagon-like peptide 1 receptor/ja]] | |||
* [[Glucagon-like peptide 1 receptor]] | * [[Glucagon-like peptide-2/ja]] | ||
* [[Glucagon-like peptide-2]] | * [[Type 2 diabetes/ja]] | ||
* [[Type 2 diabetes]] | * [[GLP-1 receptor agonist/ja]] : [[albiglutide/ja]], [[dulaglutide/ja]], [[exenatide/ja]], [[liraglutide/ja]], [[lixisenatide/ja]], [[semaglutide/ja]], [[tirzepatide/ja]] | ||
* [[GLP-1 receptor agonist]] | * [[Dipeptidyl peptidase-4/ja]] | ||
* [[Dipeptidyl peptidase-4]] | * [[Glucose-dependent insulinotropic peptide/ja]] | ||
* [[Glucose-dependent insulinotropic peptide]] | |||
| | ||